Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Vox Sanguinis|February 27, 2016
Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamideA Rimondo, S Bramanti, R Crocchiolo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2009
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell supportL Castagna, S Bramanti, A Levis, et al.Bone Marrow Transplantation|November 5, 2013
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphomaA Raiola, A Dominietto, R Varaldo, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 5, 2015
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxisR Crocchiolo, S Bramanti, A Vai, et al.Bone Marrow Transplantation|January 27, 2015
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplantL Castagna, R Crocchiolo, L Giordano, et al.Bone Marrow Transplantation|September 16, 2014
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomasL Castagna, S Bramanti, S Furst, et al.Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.Bone Marrow Transplantation|January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.Bone Marrow Transplantation|October 31, 2017
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)L Giaccone, G Mancini, N Mordini, et al.Pageof 1